Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers
Clinical trial NCT03144934 · COMPLETED
Trial details
- NCT number
- NCT03144934
- Sponsor
- Genexine, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-16
- Primary completion
- 2018-03-22
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.